Immunology

As leading experts in autoimmune diseases and therapies, we focus on treatments that will improve the standard of care for this generation and the next.

abbvie-immunology-illustration@2x

Exploring Uncharted Territories of Treatment

We continue to push innovation within our immunology pipeline—considering multiple scientific approaches and investigating novel solutions to help improve patient care across a variety of autoimmune diseases with unmet needs.

150+ active clinical trials in immunology

6 new molecular compounds in Phase I, II or III clinical trials in immunology

9 immune-mediated inflammatory conditions being investigated

50+ countries with active clinical trials in immunology

abbvie-video-immunology
Our scientists are more determined than ever to make a difference in patients’ lives.